Short answer
ORTHOPEDIATRICS CORP (KIDS) filed its Q1 2026 10-Q quarterly report on May 1, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $59M (up 13.3% year over year) with net income of −$11M.
Q1 2026 key financials · XBRL
- Revenue
- $59M
- +13.3% YoY
- Net income
- −$11M
- −0.3% YoY
- Operating margin
- -14.0%
- Gross margin
- 73.1%
- EPS (diluted)
- −$0.45
- +2.2% YoY
Source: XBRL data from the ORTHOPEDIATRICS CORP (KIDS) Q1 2026 10-Q on SEC EDGAR. USD.
ORTHOPEDIATRICS CORP Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- MD&A excerpt ends before quarterly financial results
- No profitability, margin, segment, cash flow, or capital deployment figures provided
Risk Factors
- No material risk-factor changes since 10-K filed March 4, 2026
- No newly added risk factor or quarter-specific trigger disclosed
- No updated regulatory, legal, or compliance risk identified
- No changed operational, competitive, or market risk identified
- No changed liquidity, debt-maturity, currency, or concentration risk identified
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other ORTHOPEDIATRICS CORP quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.